Documents
Institutional
Fred Abbott
F. M. Abbott, Global Pharmaceutical Regulation 2017 - Introduction - Flowchart Slide
Frederick Abbott, Using Competition Law to Address Access and Innovation Barriers in the Pharmaceutical Sector,Global Pharmaceutical Regulation 2017, April 15, 2017
Frederick Abbott, Excessive Pharmaceutical Prices and Competition Law: Doctrinal Development to Protect Public Health, UC Irvine Law Review, Volume 6, Issue 3, Spring 2017, Forthcoming
Brief of Amicus Curiae (F. Abbott) in Support of Petitioner in Impression Products v. Lexmark International, US Supreme Court, No. 15-1189, filed January 20, 2017
Ryan Abbott
Ryan Abbott, Big Data and the New Regulatory Regime, Global Pharmaceutical Regulation 2017, FSU College of Law, April 14, 2017
Ryan Abbott & Ian Ayres, Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices, 64 Duke Law Journal
Jorge Bermudez
Dr. Jorge Bermudez, 2016: Two Striking Reports: United Nations Secretary-General’s High-Level Panel on Access to Medicines; Lancet Commission on Essential Medicines, Global Pharmaceutical Regulation 2017, FSU College of Law,
Jicui Dong
Jicui Dong, Promoting Local Production of Quality Medical Products to Improve Access: WHO Perspective, Global Pharmaceutical Regulation
Nick Drager
Nick Drager, Accelerating TB Vaccine Research & Development Through Partnership, Global Pharmaceutical Regulation 2017, FSU College of Law
Joe Fortunak
Joseph Fortunak, Global Production, Regulatory, and Trade Environment, Global Pharmaceutical Regulation 2017, FSU College of Law,
Jamie Love
Jerry Reichman
Jerome Reichman, Global Intellectual Property Strategies for a Redesigned Microbial Research Commons, Global Pharmaceutical Regulation 2017, FSU College of Law
Jerome H. Reichman, Paul F. Uhlir & Tom Dedeurwaerdere, Governing Digitally Integrated Genetic Resources, Data, and Literature (2016)
Xavier Seuba
Xavier Seuba, Disputes over Biosimilar Regulations - Approval of Biosimilars and Changes Impacting Already Approved Products, Global Pharmaceutical Regulation 2017, FSU College of Law
Dilip Shah
Current News
Ben Adams, The top 10 pharma R&D budgets in 2016, Fierce Biotech
Dana A. Elfin & Madi Alexander, Drug Industry May Face New Areas of Antitrust Scrutiny, Bloomberg BNA,
Preetika Rana, China Emerges as Powerhouse for Biotech Drugs, Wall St. J.
Lena H. Sun, The Trump administration is ill-prepared for a global pandemic, Wash. Post
Jeff Kolkey, Rockford lawsuit: Pharmaceutical company gouged city for drug used to treat babies, Rockford Reg. Star (rrstar.com)
John McCormick & Jared S. Hopkins, Drugmaker Group's Ad Campaign Counters Trump's ‘Murder’ Charge, BNA Bloomberg
Ed Taylor, Brazil Regulator Rejects Gilead Patent Request for Hepatitis C Drug, BNA Bloomberg, Mar. 31, 2017
As Health Care Debate Shifts, Senator Franken and Senate Colleagues Lead Milestone Effort to Bring Down Prescription Drug Prices, Press Release
FTC Press Release, Mallinckrodt Will Pay $100 Million to Settle FTC, State Charges It Illegally Maintained its Monopoly of Specialty Drug Used to Treat Infants
UK Competition and Markets Authority, CMA fines Pfizer and Flynn £90 million for drug price hike to NHS, Press Release